Pulmonary hypertension and reopening of the ductus arteriosus in an infant treated with diazoxide

J Pediatr Endocrinol Metab. 2011;24(7-8):603-5. doi: 10.1515/jpem.2011.238.

Abstract

Diazoxide is the main therapeutic agent for persistent hyperinsulinemic hypoglycemia. Generally, it is tolerated well, but rarely it can cause severe life-threatening complications. We report a neonate who was treated with diazoxide for hyperinsulinemic hypoglycemia. On the 6th day of the treatment we observed sepsis-mimicking symptoms, mild pulmonary hypertension, and re-opening of the ductus arteriosus. All these findings resolved dramatically shortly after discontinuation of treatment. To our knowledge, this is the first reported case of re-opening of the ductus arteriosus due to diazoxide toxicity.

Publication types

  • Case Reports

MeSH terms

  • Diagnosis, Differential
  • Diazoxide / adverse effects*
  • Diazoxide / therapeutic use
  • Ductus Arteriosus, Patent / chemically induced*
  • Humans
  • Hyperinsulinism / drug therapy
  • Hyperinsulinism / physiopathology
  • Hypertension, Pulmonary / chemically induced*
  • Hypoglycemia / etiology
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use
  • Infant, Newborn
  • Male
  • Recurrence
  • Sepsis / diagnosis
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Hypoglycemic Agents
  • Diazoxide